Abstract
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive disorder characterized by thrombocytopenia from failure of megakaryopoiesis. CAMT is one of the bone marrow failure syndromes, and the disease progression may involve other lineages leading to pancytopenia. The genetic background of CAMT is mutations in the MPL gene encoding the thrombopoietin receptor. Here, we describe a Korean male with CAMT. Molecular genetic analyses by direct sequencing revealed that he was compound heterozygous for two nonsense mutations in MPL, Tyr63X (c.189C>A), and Arg357X (c.1069C>T), the latter being a novel mutation.
Original language | English |
---|---|
Pages (from-to) | 304-306 |
Number of pages | 3 |
Journal | Pediatric Blood and Cancer |
Volume | 56 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2011 |
Keywords
- Congenital amegakaryocytic thrombocytopenia
- MPL
- Mutation